Home
>
National Drug Code (NDC)
>
TachoSil
TachoSil - 0944-8703-05 - (THROMBIN HUMAN and FIBRINOGEN)
Drug Information of TachoSil
| Product NDC: | 0944-8703 |
| Proprietary Name: | TachoSil |
| Non Proprietary Name: | THROMBIN HUMAN and FIBRINOGEN |
| Active Ingredient(s): | 2; 5.5 [USP'U]/1; mg/1 & nbsp; THROMBIN HUMAN and FIBRINOGEN |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | PATCH |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TachoSil
| Product NDC: | 0944-8703 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125351 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100809 |
Package Information of TachoSil
| Package NDC: | 0944-8703-05 |
| Package Description: | 5 POUCH in 1 CARTON (0944-8703-05) > 1 BLISTER PACK in 1 POUCH > 1 PATCH in 1 BLISTER PACK |
NDC Information of TachoSil
| NDC Code | 0944-8703-05 |
| Proprietary Name | TachoSil |
| Package Description | 5 POUCH in 1 CARTON (0944-8703-05) > 1 BLISTER PACK in 1 POUCH > 1 PATCH in 1 BLISTER PACK |
| Product NDC | 0944-8703 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | THROMBIN HUMAN and FIBRINOGEN |
| Dosage Form Name | PATCH |
| Route Name | TOPICAL |
| Start Marketing Date | 20100809 |
| Marketing Category Name | BLA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | FIBRINOGEN HUMAN; THROMBIN HUMAN |
| Strength Number | 2; 5.5 |
| Strength Unit | [USP'U]/1; mg/1 |
| Pharmaceutical Classes | Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] |
